SYRE

Spyre Therapeutics (SYRE)

Spyre Therapeutics Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:SYRE

1 2 3 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/06/18	20:30	PR Newswire (US)	Spyre Therapeutics Announces First Participants Dosed in Phase 1 Trial of SPY001, its Novel Half-life Extended anti-α4β7 Antibody, for the Treatment of Inflammatory Bowel Disease	NASDAQ:SYRE	Spyre Therapeutics Inc
2024/06/04	06:23	PR Newswire (US)	Spyre Therapeutics Announces Grants of Inducement Awards	NASDAQ:SYRE	Spyre Therapeutics Inc
2024/05/31	05:33	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:SYRE	Spyre Therapeutics Inc
2024/05/29	21:30	PR Newswire (US)	Spyre Therapeutics to Participate in the Jefferies Global Healthcare Conference	NASDAQ:SYRE	Spyre Therapeutics Inc
2024/05/17	05:10	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:SYRE	Spyre Therapeutics Inc
2024/05/17	05:10	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:SYRE	Spyre Therapeutics Inc
2024/05/17	05:10	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:SYRE	Spyre Therapeutics Inc
2024/05/17	05:10	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:SYRE	Spyre Therapeutics Inc
2024/05/17	05:10	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:SYRE	Spyre Therapeutics Inc
2024/05/17	05:10	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:SYRE	Spyre Therapeutics Inc
2024/05/17	05:10	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:SYRE	Spyre Therapeutics Inc
2024/05/17	05:05	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:SYRE	Spyre Therapeutics Inc
2024/05/15	20:40	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:SYRE	Spyre Therapeutics Inc
2024/05/15	20:30	PR Newswire (US)	Spyre Therapeutics Appoints Accomplished Biopharma Leader Dr. Sandra Milligan to its Board of Directors	NASDAQ:SYRE	Spyre Therapeutics Inc
2024/05/10	05:11	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:SYRE	Spyre Therapeutics Inc
2024/05/10	05:08	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:SYRE	Spyre Therapeutics Inc
2024/05/10	05:02	PR Newswire (US)	Spyre Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update	NASDAQ:SYRE	Spyre Therapeutics Inc
2024/05/04	06:00	PR Newswire (US)	Spyre Therapeutics Announces Grants of Inducement Awards	NASDAQ:SYRE	Spyre Therapeutics Inc
2024/04/02	06:00	PR Newswire (US)	Spyre Therapeutics Announces Grants of Inducement Awards	NASDAQ:SYRE	Spyre Therapeutics Inc
2024/03/18	21:00	PR Newswire (US)	Spyre Therapeutics Announces $180 Million Private Placement	NASDAQ:SYRE	Spyre Therapeutics Inc
2024/03/06	07:15	Edgar (US Regulatory)	Form POS AM - Post-Effective amendments for registration statement	NASDAQ:SYRE	Spyre Therapeutics Inc
2024/03/02	07:25	PR Newswire (US)	Spyre Therapeutics Announces Grants of Inducement Awards	NASDAQ:SYRE	Spyre Therapeutics Inc
2024/03/01	20:14	Edgar (US Regulatory)	Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]	NASDAQ:SYRE	Spyre Therapeutics Inc
2024/03/01	07:06	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:SYRE	Spyre Therapeutics Inc
2024/03/01	06:14	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:SYRE	Spyre Therapeutics Inc
2024/03/01	06:05	PR Newswire (US)	Spyre Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update	NASDAQ:SYRE	Spyre Therapeutics Inc
2024/02/26	21:30	PR Newswire (US)	Spyre Therapeutics to Participate in the 44th Annual TD Cowen Health Care Conference	NASDAQ:SYRE	Spyre Therapeutics Inc
2024/02/21	11:21	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:SYRE	Spyre Therapeutics Inc
2024/02/15	10:47	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:SYRE	Spyre Therapeutics Inc
2024/02/15	06:05	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:SYRE	Spyre Therapeutics Inc